Skip to content
Recall Observatory FDA recall evidence

Drug product

Sennazon (sennosides) Syrup, 8.8 mg, 8 fl. oz. (237 mL) bottle, Mfd. for: Bayshore Pharmaceuticals, Tampla, FL 33619, NDC 76518-100-08.

D-1520-2016

August 08, 2016

Class II

Product summary

Firm
Pharmatech LLC
Event
Event 74874
Status
Terminated
Classification
Class II
Quantity
1,008 bottles
Official record key
drug-enforcement:D-1520-2016

Official wording

Reason: CGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia.

Code information: Lot #: 20391519, Exp 11/17

Distribution pattern: Nationwide

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations